Company Filing History:
Years Active: 2014
Title: Innovations of Kai-Hang Su in Bioassay Technology
Introduction
Kai-Hang Su is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of bioassay technology, particularly through his innovative work involving nanoplasmonic resonators. His research focuses on enhancing the sensitivity and efficiency of enzymatic activity measurements.
Latest Patents
Kai-Hang Su holds a patent for a "Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity." This invention features a nanoplasmonic resonator (NPR) that comprises a metallic nanodisk with alternating shielding layers. The NPR is designed to have a tagged biomolecule conjugated or tethered to its surface, allowing for highly sensitive measurement of enzymatic activity. The technology enhances Raman signals in a reproducible manner, enabling fast detection of protease and enzyme activity, such as Prostate Specific Antigen (paPSA), in real-time at picomolar sensitivity levels. Experiments conducted on extracellular fluid (ECF) from paPSA-positive cells demonstrate the NPR's capability for specific detection in complex bio-fluid backgrounds during real-time single-step detection in very small sample volumes.
Career Highlights
Kai-Hang Su is affiliated with the University of California, where he continues to advance his research in bioassay technologies. His work has garnered attention for its potential applications in medical diagnostics and research.
Collaborations
Some of his notable coworkers include Xiang Zhang and Jonathan A Ellman, who have collaborated with him on various research projects.
Conclusion
Kai-Hang Su's innovative contributions to bioassay technology exemplify the potential of nanoplasmonic resonators in enhancing enzymatic activity measurements. His work not only advances scientific understanding but also paves the way for future applications in medical diagnostics.